These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25877711)

  • 1. [Efficacy observation of 0.1% bromfenac sodium eye drops on relieving the post-LASEK irritative symptoms].
    Dong Y; Zhang Y; Xia Y; Wang B; Chen Y
    Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):51-4. PubMed ID: 25877711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of clinical effects of bromfenac sodium ophthalmic solution 0.1% versus glucocorticoids for post-LASEK usage].
    Chen S; Jiang Y; Yu C; Li Y
    Zhonghua Yan Ke Za Zhi; 2015 Jan; 51(1):45-50. PubMed ID: 25877710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS; Kennard MG; Boghossian AJ
    Adv Ther; 2007; 24(6):1278-85. PubMed ID: 18165210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the effects of 0.1% bromfenac sodium eye drops and corticosteroids after small incision lenticule extraction].
    Jiang Y; Li Y; Jin YM; Zhang JY
    Zhonghua Yan Ke Za Zhi; 2017 Jan; 53(1):18-22. PubMed ID: 28162195
    [No Abstract]   [Full Text] [Related]  

  • 5. [The clinical efficacy of 0.1% bromfenac sodium hydrate ophthalmic solution after excimer laser in situ keratomileusis].
    Xu Y; Zhao X; Zhang FJ; Wang MM; Guo N; Zheng Y; Liu J; Zhang QL
    Zhonghua Yan Ke Za Zhi; 2013 Apr; 49(4):320-6. PubMed ID: 23900091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK.
    Wang XJ; Wong SH; Givergis R; Chynn EW
    Clin Ophthalmol; 2011; 5():1451-7. PubMed ID: 22034570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cyclooxygenase inhibitory activity and ocular anti-inflammatory effects of ketorolac tromethamine and bromfenac sodium.
    Waterbury LD; Silliman D; Jolas T
    Curr Med Res Opin; 2006 Jun; 22(6):1133-40. PubMed ID: 16846546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.
    Sher NA; Golben MR; Bond W; Trattler WB; Tauber S; Voirin TG
    J Refract Surg; 2009 Feb; 25(2):214-20. PubMed ID: 19241773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S; Ram J; Bansal R; Pandav SS; Gupta A
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of postoperative pain following laser-assisted subepithelial keratectomy and transepithelial photorefractive keratectomy: a prospective, random paired bilateral eye study.
    Wang D; Chen G; Tang L; Li Q
    Eye Sci; 2014 Sep; 29(3):155-9. PubMed ID: 26011971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsification.
    Bucci FA; Waterbury LD
    Adv Ther; 2011 Dec; 28(12):1089-95. PubMed ID: 22105509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of bromfenac sodium ophthalmic solution for treatment of dry eye disease.
    Fujishima H; Fuseya M; Ogata M; Murat D
    Asia Pac J Ophthalmol (Phila); 2015; 4(1):9-13. PubMed ID: 26068607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Trattler W; McDonald M
    Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of efficacy of bromfenac sodium 0.1% ophthalmic solution and fluorometholone 0.02% ophthalmic suspension for the treatment of allergic conjunctivitis.
    Fujishima H; Fukagawa K; Takano Y; Tanaka M; Okamoto S; Miyazaki D; Yamada J; Fukushima A; Uchio E; Nakagawa Y
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):265-70. PubMed ID: 19348602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.
    Miyake-Kashima M; Takano Y; Tanaka M; Satake Y; Kawakita T; Dogru M; Asano-Kato N; Fukagawa K; Fujishima H
    Jpn J Ophthalmol; 2004; 48(6):587-90. PubMed ID: 15592786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous prostaglandin E(2) of cataract patients at trough ketorolac and bromfenac levels after 2 days dosing.
    Bucci FA; Waterbury LD
    Adv Ther; 2009 Jun; 26(6):645-50. PubMed ID: 19568702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic effect of preoperative topical nonsteroidal antiinflammatory drugs on postoperative pain after laser-assisted subepithelial keratectomy.
    Kim SK; Hong JP; Nam SM; Stulting RD; Seo KY
    J Cataract Refract Surg; 2015 Apr; 41(4):749-55. PubMed ID: 25840299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical bromfenac sodium for long-term management of vernal keratoconjunctivitis.
    Uchio E; Itoh Y; Kadonosono K
    Ophthalmologica; 2007; 221(3):153-8. PubMed ID: 17440276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
    Solomon KD; Donnenfeld ED; Raizman M; Sandoval HP; Stern K; VanDenburgh A; Cheetham JK; Schiffman R;
    J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotrophic Keratopathy after wide retinal endolaser and postoperative Ketorolac eye drops: A case series.
    Fossati G; Bartoli E; Montericcio A; Buzzi M; Barone G; Santoru F; Allegrini D; Romano MR; Panico C
    Eur J Ophthalmol; 2024 May; 34(3):NP18-NP21. PubMed ID: 38254249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.